Pharmaceutical composition having uniform drug distribution and potency
作者： Daniel Scott Gierer
DOI:
关键词: Manufacturing process 、 Biomedical engineering 、 Composition (combinatorics) 、 Potency 、 Materials science 、 Nanotechnology 、 Active ingredient
摘要: Pharmaceutical compositions having uniform drug distribution and potency utilizing laxofoxifene as an active ingredient containing a silicon dioxide to reduce loss of the during manufacturing process methods for such are disclosed.
google.ca 参考文章(35)
Robert M. Franz, Film coated tablet of ranitidine HCl ,(1988)
Samuel H. Yalkowsky, Process for preparing solid unit dosage forms of ultra-low dose drugs ,(1982)
A Knecht, D Hanssen, Method of manufacturing rapidly disintegrating pharmaceutical tablets ,(1970)
Charles K. Chiu, Morgan Meltz, (-) cis-6(s)-phenyl-5(r)[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate ,(1996)
Jiwaji Gulabrao Suryawanshi, Eric Joel Benjamin, Wendy Ann Dulin, Pharmaceutical compositions of estrogenic agents ,(2001)
James R. Millis, Alan Berry, Richard P. Burlingame, Process and Materials for Production of Glucosamine ,(1999)
Richard B. Taylor, E. C. Henley, Composition for and method of preventing or treating breast cancer ,(2000)
Alfonso R. Gennaro, Remington: The Science and Practice of Pharmacy ,(2003)
Kristin Sue Marron, Christopher Randall Schmid, James Patrick Sluka, Substituted benzo(b)thiophene compounds having activity as selective estrogen receptor modulators ,(1997)